KAPA (STOCKS)
Kairos Pharma, Ltd.
$0.440100
+0.000100 (+0.02%)
Prev close: $0.440000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- John S. Yu
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9.44M
- Employees
- 4
- P/E (TTM)
- -1.49
- P/B (TTM)
- 1.77
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $157.00K |
| Operating Expenses | $6.00M |
| Research and Development | $2.33M |
| Other Operating Expenses | $3.67M |
| Operating Income/Loss | -$6.00M |
| Income/Loss From Continuing Operations After Tax | -$5.84M |
| Income/Loss From Continuing Operations Before Tax | -$5.84M |
| Net Income/Loss | -$5.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$5.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$5.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.30 |
| Diluted Earnings Per Share | -$0.30 |
| Basic Average Shares | 59,235,805 |
| Diluted Average Shares | 59,235,805 |
| Assets | $5.74M |
| Current Assets | $4.44M |
| Noncurrent Assets | $1.30M |
| Intangible Assets | $22.00K |
| Other Non-current Assets | $1.28M |
| Liabilities | $431.00K |
| Current Liabilities | $431.00K |
| Noncurrent Liabilities | $0.00 |
| Equity | $5.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.31M |
| Liabilities And Equity | $5.74M |
| Net Cash Flow From Operating Activities | -$3.76M |
| Net Cash Flow From Operating Activities, Continuing | -$3.76M |
| Net Cash Flow From Investing Activities | -$59.00K |
| Net Cash Flow From Investing Activities, Continuing | -$59.00K |
| Net Cash Flow From Financing Activities | $3.82M |
| Net Cash Flow From Financing Activities, Continuing | $3.82M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$5.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$5.84M |
| Other Comprehensive Income/Loss | $0.00 |